As of 2024-12-12, the Intrinsic Value of Eupraxia Pharmaceuticals Inc (EPRX.TO) is
-6.49 CAD. This EPRX.TO valuation is based on the model Peter Lynch Fair Value.
With the current market price of 4.66 CAD, the upside of Eupraxia Pharmaceuticals Inc is
-239.20%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-6.49 CAD
Intrinsic Value
EPRX.TO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-6.49 - -6.49 |
-6.49 |
-239.20% |
| DDM - Stable |
(32.11) - 261.94 |
114.91 |
2366.0% |
| DDM - Multi |
(0.34) - 2.03 |
(0.78) |
-116.7% |
EPRX.TO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
166.00 |
| Beta |
-0.08 |
| Outstanding shares (mil) |
35.62 |
| Enterprise Value (mil) |
157.34 |
| Market risk premium |
5.10% |
| Cost of Equity |
5.19% |
| Cost of Debt |
5.00% |
| WACC |
5.10% |